Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2015-02-28
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Additionally, this study will evaluate:
* the robot precision,
* the robot detection robustness,
* the software and device ergonomics,
* the device security.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Robot
A robot will be used and it's position will be evaluated
Robot
Use of the robot to locate the fictional needle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Robot
Use of the robot to locate the fictional needle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* person with height is under 1m90,
* person with abdomen height is under 28 cm,
* person with abdomen width is between 26 cm to 50 cm,
* person able to hold his breath during 30 seconds,
* person affiliated to social security or similarly regime,
* signed consent for participation in the study.
Exclusion Criteria
* claustrophobic person,
* protected person referred to in Articles L1121-5 to L1121-8 of the Code of Public Health
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TIMC-IMAG
OTHER
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Grenoble
Grenoble, Isère, France
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Website of the Grenoble clinical investigation center - Technological Innovation
Website of TIMC-IMAG laboratory
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DCIC 14-36
Identifier Type: -
Identifier Source: org_study_id